Latest colorectal cancer News | Page 5

What are postbiotics and how can they improve our gut health?
Imjudo in combination with Imfinzi approved in US for patients with unresectable liver cancer
Going with your gut
Guidelines on breast cancer surgery need revision, find researchers
Success for University of Otago, Christchurch, Researchers with CMRF Major Project Grant
Researchers explore use of light-activated treatment to target wider variety of cancers
New technique boosts online medical search results
New Study Links Ultra-Processed Foods and Colorectal Cancer in Men
Are Costly New Prescription Drugs Worth Price?
Enhertu significantly delayed disease progression in DESTINY-Breast02 Phase III trial vs. physician’s choice of treatment
Enhertu granted Priority Review in US for patients with HER2-low metastatic breast cancer
Scientists identify key molecular protector of gut health
AGA to join Fight CRC at White House to address colorectal cancer screening needs
Pat Morin appointed deputy scientific director of Ludwig Institute for Cancer Research
Gut bacteria potential key to IBD and colon cancer prevention
Enhertu recommended for approval in EU by CHMP for patients with HER2-positive metastatic breast cancer treated with prior
AGA releases evidence-based principles to guide creation of national colorectal cancer screening approach
‘The Rock’ assumes presidency of AGA
New cancer subtype may illuminate treatment strategy
Radiation oncology services in Albany to be provided by GenesisCare
$900,000 funding for Otago health researchers
Enhertu granted Breakthrough Therapy Designation in US for patients with HER2-low metastatic breast cancer
Enhertu granted Priority Review in US for patients with previously treated HER2-mutant metastatic non-small cell lung cancer
Cannabis causes more cancers than tobacco
Greater awareness of key bowel cancer risk factors needed, new research finds
Nitrate levels in drinking water and bowel cancer
Enhertu significantly improved both progression-free and overall survival in DESTINY-Breast04 trial
Baylor Creceives more than $15.6 million in CPRIT funding
How our genes influence our gut health
Key growth factor protects gut from IBD
Trial of wearable health technology for cancer patients opens
Young cancer rates rising in SA
Imfinzi plus tremelimumab demonstrated unprecedented survival in 1st-line unresectable liver cancer with 31% of patients alive
Enhertu granted Priority Review in US for patients with HER2-positive metastatic breast cancer treated with prior anti-HER2-based
No more surprise bills: Private insurance plans must cover full colorectal cancer screening continuum
AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza data
Development of New Gastric Cancer Model: Identification of Gastric Cancer Stem Cells
Colon cancer breakthrough – combo therapy halts cell growth
Researchers on mission to improve cancer outcomes
Prime time: First therapeutic clinical trial of C’Dots underway
Cancer survival rates are improving in Australia
Cancer survival rates continue to improve, while death and incidence rates fall
U.S. Multi-Society Task Force on CRC Releases Updated Screening Recommendations
Govt must start phase out of synthetic nitrogen fertiliser
Nitrate in drinking water could cause up to 100 cases of bowel cancer in NZ
Imfinzi plus tremelimumab significantly improved overall survival in HIMALAYA Phase III trial
Research focus on gut diseases
Cancer costs U.S. more than $156 billion, with drugs leading expense